• |
  • |
  • |
  • |
Donate

Project

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome

Center:
Fiscal Year:
2015
Contact Information:
Project Description:
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Keyword(s):
Core Function(s):
Performing Direct and/or Demonstration Services, Performing Research or Evaluation
Area of Emphasis
Health-Related Activities
Target Audience:
Students/Trainees (long or intermediate trainees), Professionals and Para-Professionals, Children/Adolescents with Disabilities/SHCN
Unserved or Under-served Populations:
Specific Groups
Primary Target Audience Geographic Descriptor:
State
Funding Source:
COVID-19 Related Data:
N/A